Schedule 13G ownership disclosure
Vistagen Therapeutics Inc
Security class unavailable · CUSIP: 92840H400
Event date: 2023-10-04
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 7.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-23-256922
- Form type
- SC 13G
- Filer
- TCG Crossover GP II, LLC
- CIK
- CIK 1969280
- Filed
- Oct 16, 2023
- Reporting period
- Oct 04, 2023
- Description
- Schedule 13G beneficial ownership